CD107a Monoclonal Antibody (B4A3), PE-Cy5 (NHP-AB093)
This product is an antibody conjugated with PE-Cy5 that was generated by immunizing mice against a human adherent peripheral blood cells. It is used only in in vitro assays.
glycosylated type I transmembrane protein that constitutes the major sialoglycoproteins
on lysosomal membranes. It is a ligand for galaptin, an S-type lectin present in
extracellular matrix, through its recognition of acetyllactosamine oligosaccharide chains,
and is a ligand for E-selectin-mediated cell adhesion. CD107a is expressed by activated T
cells, macrophages, dendritic cells, activated platelets, tonsillar epithelium, and some
tumor cell lines, including U937 and KG1a. It is also a widely expressed intracellular
antigen. LAMP-1 may function in protecting the inner surface of the lysosomal membrane
by forming a barrier to lysosomal hydrolases. The upregulation of both CD107a and
CD107b on the surface of tumor cell lines has been associated with their enhanced
metastatic potential where they may increase adhesion to extracellular matrix and
endothelium.
- CD107a Monoclonal Antibody (B4A3), PE-Cy5 (NHP-AB093) Data Sheet: Detailed information. datasheet
There are currently no customer reviews or questions for CD107a Monoclonal Antibody (B4A3), PE-Cy5 (NHP-AB093). Click the button below to contact us or submit your feedback about this product.
Your research is unique, and we understand that standard products may not always fit. Our team of experts specializes in custom NHP sample collections. We can design a tailored protocol to meet your specific research requirements, including samples with unique anticoagulant types, customized volumes, or from specific disease models.
You may also be interested in…
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.